Works by Sevindik, O. G.

WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).

Published in:

Hematological Oncology, 2023, v. 41, p. 208, doi. 10.1002/hon.3163_136

By:

• Fosså, A.;
• Ozcan, M.;
• Song, Y.;
• Lee, S. T.;
• Mensah, F.;
• Modi, D.;
• Kim, W. S.;
• Paszkiewicz‐Kozik, E.;
• Sawalha, Y.;
• Sevindik, O. G.;
• Norasetthada, L.;
• Santoro, A.;
• Pathiraja, K.;
• Chakraborty, S.;
• Marinello, P.;
• Lavie, D.

Publication type:

Article